
Verweise
- Frampton GM et al. Nat Biotechnol 2013; 31: 1023–1031.
- Clark TA et al. J Mol Diagn 2018; 20: 686–702.
- He J et al. Blood 2016; 127: 3004–3014.
- Drilon A et al. Clin Cancer Res 2015; 21: 3631–3639.
- Rankin A et al. Oncologist 2016; 21: 1306–1314.
- Ross JS et al. Cancer 2016; 122: 2654–2662.
- Suh JH et al. Oncologist 2016; 21: 684–691.
- Hirshfield KM et al. Oncologist 2016; 21: 1315–1325.
- Ali SM et al. Oncologist 2016; 6: 762–770.
- Schrock AB et al. Clin Cancer Res 2016; 22: 3281–3285.
- Foundation Insights. Available at: https://www.foundationmedicine.com/insights-and-trials/foundation-insights (Accessed March 2019).